Nikolic-Vukosavljevic Dragica,Jankovic Radmila N,Grujic-Adanja Gordana,Neskovic-Konstantinovic Zora B,Mitrovic LB (2001) Immunoradiometric assay of pS2: Estrogen-regulated vs. nonestrogen regulated pS2 expression in relation to clinico-pathological features of breast cancer, JOURNAL OF TUMOR MARKER ONCOLOGY, vol. 16, br. 3, str. 207-215 (Article) 

Jelic Svetislav B,Mitrovic LB,Radosavljevic Davorin Z,Elezar E,Babovic Nada Lj,Kovcin Vladimir N,Tomasevic Zorica I,Kovacevic S,Gavrilovic Dusica,Radulovic Sinisa S (2001) Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study, LUNG CANCER, vol. 34, br. 1, str. 1-13 (Article) 

Ivanovic Vesna,Todorovic-Rakovic Natasa,Demajo Miroslav A,Neskovic-Konstantinovic Zora B,Nikolic-Vukosavljevic Dragica,Ivansevic-Milovanovic Olivera,Mitrovic LB (2001) Detection of transforming growth factor-beta 1 in human plasma - A pilot study on breast cancer patients, JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, vol. 20, br. 2, str. 81-87 (Article) 

Nikolic-Tomasevic Zorica I,Jelic Svetislav B,Popov Ivan P,Radosavljevic Davorin Z,Mitrovic LB (2001) Tumor 'flare' hypercalcemia - An additional indication for bisphosphonates?, ONCOLOGY, vol. 60, br. 2, str. 123-126 (Article) 

Nikolic-Vukosavljevic Dragica,Grujic-Adanja Gordana,Jankovic Radmila N,Neskovic-Konstantinovic Zora B,Brankovic-Magic Mirjana V,Mitrovic LB (2001) pS2 protein in breast carcinomas: Cut-off value of estrogen-regulated expression, NEOPLASMA, vol. 48, br. 1, str. 1-6 (Article) 

Bosnjak Snezana M,Radulovic Sinisa S,Neskovic-Konstantinovic Zora B,Mitrovic LB (2000) Patient statement of satisfaction with antiemetic treatment is related to quality of life, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol. 23, br. 6, str. 575-578 (Article) 

Bosnjak Snezana M,Neskovic-Konstantinovic Zora B,Radulovic Sinisa S,Susnjar Snezana V,Mitrovic LB (2000) High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer, JOURNAL OF CHEMOTHERAPY, vol. 12, br. 5, str. 446-453 (Article) 

Colakovic Slobodanka,Lukic Vesna,Mitrovic LB,Jelic Svetislav B,Susnjar Snezana V,Marinkovic J (2000) Prechemotherapy serum CA125 level, CA125 kinetics and its half-life as prognostic factors in advanced ovarian cancer., ANNALS OF ONCOLOGY, vol. 11, br. , str. 82-83 (Meeting Abstract) 

Tomasevic Zorica I,Jelic Svetislav B,Popov Ivan P,Radosavljevic Davorin Z,Mitrovic LB (2000) Tumor "flare" hypercalcemia: One more indication for bisphosphonates usage?, ANNALS OF ONCOLOGY, vol. 11, br. , str. 39-39 (Meeting Abstract) 

Colakovic Slobodanka,Lukic Vesna,Mitrovic LB,Jelic Svetislav B,Susnjar Snezana V,Marinkovic J (2000) Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer, INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. 15, br. 2, str. 147-152 (Article) 

Neskovic-Konstantinovic Zora B,Nikolic-Vukosavljevic Dragica,Brankovic-Magic Mirjana V,Mitrovic LB,Spuzic Ivan (2000) Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction, NEOPLASMA, vol. 47, br. 2, str. 107-113 (Article) 

Susnjar Snezana V,Vasovic Suzana,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Lukic Vesna,Colakovic Slobodanka,Mitrovic LB,Jelic Svetislav B,Radulovic Sinisa S (1999) Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study, TUMORI, vol. 85, br. 6, str. 478-482 (Article)